• Login
Thursday, March 5, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Switzerland

Swiss meter firm Landis+Gyr shifts management to US

GenevaTimes by GenevaTimes
January 30, 2026
in Switzerland
Reading Time: 9 mins read
0
Swiss meter firm Landis+Gyr shifts management to US
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


Landis+Gyr CEO: Operational management already fully in the USA

Landis+Gyr CEO: Operational management already fully in the USA


Keystone-SDA

Swiss electric meter manufacturer Landis+Gyr has relocated the majority of its operational management team to Atlanta in the United States.





Generated with artificial intelligence.


This content was published on


January 29, 2026 – 09:13

+ Get the most important news from Switzerland in your inbox

This was announced by CEO Peter Mainz as part of a strategic focus on the Americas and Asia-Pacific regions.

Mainz said that he himself currently lives in the US. In addition, customers could be looked after much better from the US headquarters.

However, the company’s headquarters will remain in Switzerland. This would allow the existing capabilities in Switzerland to be retained, Mainz added.

Mainz did not question the listing on the Swiss stock exchange SIX. He justified the retention of the listing with the existing shareholder base.

According to him, they should also be able to participate in the company’s growth in the future and benefit from the expected “increase in value”.

More

Roche plans to invest 50 billion dollars in the USA within 5 years

More

Swiss pharma giant Roche to invest $50bn in US within five years




This content was published on


Apr 22, 2025



After Novartis, fellow Swiss pharmaceutical company Roche plans to invest up to $50 billion in the US over the next five years.



Read more: Swiss pharma giant Roche to invest $50bn in US within five years


Translated from German by AI/mga

We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.  

Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.

If you have any questions about how we work, write to us at english@swissinfo.ch

Articles in this story

Read More

Previous Post

Nuuk mayor blasts comedian for trying to raise US flag in Greenland – POLITICO

Next Post

Let’s Debate: Which College Football Coaching Hire Is Most Puzzling, Impactful?

Next Post
Let’s Debate: Which College Football Coaching Hire Is Most Puzzling, Impactful?

Let's Debate: Which College Football Coaching Hire Is Most Puzzling, Impactful?

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin